Benzotriazoles reactivate and decrease latent HIV-1 both in vitro and ex vivo Reactivation is independent of T cell proliferation or global immune activation Inhibition of STAT5 SUMOylation is the main target of benzotriazoles Benzotriazoles increase binding of STAT5 to the HIV-1 LTR